World Investment Advisors LLC Buys Shares of 100,000 Milestone Scientific Inc. (NYSE:MLSS)

World Investment Advisors LLC purchased a new position in Milestone Scientific Inc. (NYSE:MLSS) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 100,000 shares of the company’s stock, valued at approximately $91,000.

Separately, Y Intercept Hong Kong Ltd bought a new position in Milestone Scientific during the third quarter worth $48,000. 5.79% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Milestone Scientific

In other news, Director Leonard Osser sold 107,984 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total transaction of $100,425.12. Following the completion of the transaction, the director now directly owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. This trade represents a 2.29 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 24.75% of the company’s stock.

Milestone Scientific Trading Up 3.5 %

MLSS opened at $0.80 on Friday. The stock has a market cap of $62.09 million, a PE ratio of -11.39 and a beta of 1.10. Milestone Scientific Inc. has a 1 year low of $0.52 and a 1 year high of $1.10. The stock’s 50 day simple moving average is $0.81 and its 200-day simple moving average is $0.86.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on MLSS shares. Benchmark reissued a “speculative buy” rating and issued a $1.25 price target on shares of Milestone Scientific in a report on Wednesday, November 20th. StockNews.com initiated coverage on shares of Milestone Scientific in a research note on Friday. They issued a “hold” rating for the company.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.